Safety and efficacy of microneedling with autologous platelet-rich plasma in chronic and stable alopecia areata
DOI:
https://doi.org/10.66344/jpad.v28i1.979Keywords:
Alopecia areata, platelet-rich plasmaAbstract
Objective Safety and efficacy of microneedling with autologous platelet-rich plasma (PRP) in chronic and stable alopecia areata.
Methods This study was conducted from September 2013-October 2015 and included 25 patients of alopecia areata attending dermatology OPD of Victoria Hospital and Bowring and Lady Curzon Hospital affiliated to Bangalore Medical College and Research Institute. Patients were included in the study based on the exclusion and inclusion criteria. It was conducted as a randomized prospective study for a period of 12 weeks. SALT score at the baseline and at the end of 12 weeks and hair regrowth at the end of 12 weeks was calculated to see the treatment response.
Results Patients showed statistically significant hair regrowth and decrease in the SALT score from baseline at the end of 12 weeks.
Conclusion Study concluded that microneedling with autologous PRP can serve as a safe and efficient treatment in cases of chronic and extensive alopecia areata for faster hair regrowth.
References
1. Seetharam KA. Alopecia areata: An update. Indian J Dermatol Venereol Leprol. 2013;79:563-75.
2. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd. Incidence of alopecia areata in Olmsted County, Minnesota,1975 through 1989. Mayo Clin Proc. 1995;70:628-33.
3. Wasserman D, Guzman-Sanchez DA, Scott K, McMichael A. Alopecia areata. Int J Dermatol. 2007;46:121-31
4. Goh C, Finkel M, Christos PJ, Sinha AA. Profile of 513 patients with alopecia areata: Associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol. 2006;20:1055-60.
5. Messenger AG. Alopecia areata. Disorders of hair. In: Griffiths CEM, Barker J, Bleiker T, Chalmers R, Creamer D, editors. Rook’s Textbook of Dermatology. 9th edn. Oxford, UK: Willey-Blackwell; 2016. P. 66.31-8.
6. Dubois M, Baumstarck-Barrau K, Gaudy-Marqueste C, Richard MA, Loundou A, Auquier P et al. Quality of life in alopecia areata: A study of 60 cases. J Invest Dermatol. 2010;130:2830-3.
7. AlKhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: Part II. Treatment. J Am Acad Dermatol. 2010;62:191-202.
8. Sohn KC, Jang S, Choi DK, Lee YS, Yoon TJ, Jeon EK et al. Effect of thioredoxin reductase 1 on glucocorticoid receptor activity in human outer root sheath cells. Biochem Biophys Res Commun. 2007;356:810-5.
9. Tan E, Tay YK, Goh CL, Chin Giam Y. The pattern of alopecia areata in Singapore – A study of 219 Asians. Int J Dermatol. 2002;41:748-53.
10. Sharma VK, Dawn G, Kumar B. Profile of alopecia areata in northern India. Int J Dermatol. 1996:35:22-7.
11. Al-Mutairi N, Eldin ON. Clinical profile and impact on quality of life: Seven years experience with patients of alopecia areata. Indian J Dermatol Venereol Leprol. 2011;77:489-93.
12. Bhat YJ, Manzoor S, Khan AR, Qayoom S. Trace element levels in alopecia areata. Indian J Dermatol Venereol Leprol. 2009;75:29-31.
13. Trink E, Sorbellini E, Bezzola P, Rodella L, Rezzani R, Ramot Y et al. A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata. Br J Dermatol. 2013;169:690-4.
14. Uebel CO, da Silva JB, Cantarelli D, Martins P. The role of platelet plasma growth factors in male pattern baldness surgery. Plast Reconstr Surg. 2006;118:1458-66; discussion 1467.
15. Deepak SH, Shwetha S. Scalp roller therapy in resistant alopecia areata. J Cutan Aesthet Surg. 2014;7:61-2.
16. Singh S. Role of platelet rich plasma in chronic alopecia areata: our centre experience. Indian J Plast Surg. 2015;48:57-9.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Nagaratna Chatnallikar, Asha GS, Leelavthy B, Revathi TN
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
